82 related articles for article (PubMed ID: 4083567)
1. Hemodynamic response to oral prenalterol in dilated decompensated cardiomyopathy as a result of cardiac and vascular effects.
Guazzi MD; Agostoni PG; Doria E; Loaldi A; Pepi M; Polese A
Angiology; 1985 Dec; 36(12):857-66. PubMed ID: 4083567
[TBL] [Abstract][Full Text] [Related]
2. [Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Ging LQ; Guazzi M
Cardiologia; 1982; 27(1):99-101. PubMed ID: 6152733
[No Abstract] [Full Text] [Related]
3. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
Strauer BE; Bohn I; Hahn B; Kment A; Motz U
J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
[TBL] [Abstract][Full Text] [Related]
4. [Chronic therapy of congestive cardiomyopathy: effects of prenalterol and digoxin].
Schwarz KR; Hofmann M; Mäurer W; Kadel C; von Olshausen K; Rauch B; Kübler W
Z Kardiol; 1985 Jul; 74(7):374-83. PubMed ID: 3929486
[TBL] [Abstract][Full Text] [Related]
5. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
[TBL] [Abstract][Full Text] [Related]
6. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
[No Abstract] [Full Text] [Related]
9. Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
Reiz S; Friedman A; Häggmark S
Acta Anaesthesiol Scand; 1981 Jun; 25(3):235-9. PubMed ID: 6119869
[TBL] [Abstract][Full Text] [Related]
10. [Effects of Prenalterol on left ventricular function of coronary patients].
Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
[TBL] [Abstract][Full Text] [Related]
11. Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
Wahr DW; Swedberg K; Rabbino M; Hoyle MJ; Curran D; Parmley WW; Chatterjee K
Am J Med; 1984 Jun; 76(6):999-1005. PubMed ID: 6731471
[TBL] [Abstract][Full Text] [Related]
12. Echocardiographic comparison between prenalterol and dobutamine.
Wester HA; Oltmanns D
Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
[TBL] [Abstract][Full Text] [Related]
13. [Circulatory effects of prenalterol (selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Lu Quo Ging ; Guazzi M
Cardiologia; 1982; 27(1):99-101. PubMed ID: 6892381
[No Abstract] [Full Text] [Related]
14. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
15. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
16. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
17. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.
Kirlin PC; Walton JA; Brymer JF; Beauman G; Pitt B
J Cardiovasc Pharmacol; 1984; 6(5):852-8. PubMed ID: 6209491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
